CONSTELLATION ALPHA CAPITAL CORPORATION (CNACU)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
John D. Dobak
Employees:
260
11099 N. TORREY PINES ROAD SUITE 100 LA JOLLA CA 92037
858-450-4222

DermTech, Inc. develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners.

Data derived from most recent annual or quarterly report
Market Cap 47.719 Million Shares Outstanding5.343 Million Avg 30-day Volume 3.115 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.5
Price to Revenue8.1136 Debt to Equity0.0309 EBITDA-111.323 Million
Price to Book Value0.769 Operating Margin0.0 Enterprise Value24.998 Million
Current Ratio EPS Growth-0.954 Quick Ratio
1 Yr BETA 0.2834 52-week High/Low 0.0 / Profit Margin-779.5834
Operating Cash Flow Growth-109.4514 Altman Z-Score Free Cash Flow to Firm 15.44 Million
View SEC Filings from CNACU instead.

View recent insider trading info

Funds Holding CNACU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CNACU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K/A: filed on 2022-11-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-31:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2022-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WOOD TODD MICHAEL CHIEF COMMERCIAL OFFICER

    • Officer
    215,099 2022-09-12 4

    IBARRA CLAUDIA CHIEF OPERATING OFFICER

    • Officer
    160,783 2022-09-12 4

    SUN KEVIN M CHIEF FINANCIAL OFFICER

    • Officer
    222,901 2022-09-06 1

    MALLOY KIRK

    • Director
    4,405 2022-07-18 2

    CAPONE MARK CHRISTOPHER

    • Director
    0 2022-07-18 2

    DOBAK JOHN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    665,295 2022-05-27 1

    ROSENMAN HERM

    • Director
    98,862 2022-05-26 2

    COLLINS CYNTHIA

    • Director
    69,121 2022-05-26 1

    POSARD MATTHEW L.

    • Director
    122,501 2022-05-26 1

    TELLADO MONICA

    • Director
    35,099 2022-05-26 1

    KERAUDY NATHALIE GERSCHTEIN

    • Director
    33,975 2022-05-26 1

    RTW INVESTMENTS, LP

    WONG RODERICK

    • 10% Owner
    2,887,216 2020-08-17 0

    YAO ZUXU CHIEF SCIENTIFIC OFFICER

    • Officer
    84,364 2020-06-24 0

    JANSEN BURKHARD CHIEF MEDICAL OFFICER

    • Officer
    84,037 2020-06-24 0

    PANCOAST SCOTT R

    • Director
    52,514 2020-06-17 0

    JACOBS GARY E.

    • Director
    • 10% Owner
    1,321,813 2020-06-17 0

    PICOZZA ENRICO

    • Director
    819,862 2020-06-17 0

    IRWIN & JOAN JACOBS TRUST DATED 6-2-80

    JACOBS IRWIN M

    JACOBS JOAN

    • 10% Owner
    1,808,434 2020-05-11 0

    SALKIND GENE

    • Director
    179,154 2020-01-30 0

    JACOBS IRWIN M

    • 10% Owner
    1,766,502 2019-08-29 0

    KEMPER STEVEN J CHIEF FINANCIAL OFFICER

    • Officer
    59,685 2019-08-29 0

    IRWIN & JOAN JACOBS TRUST DATED 6-2-80

    • 10% Owner
    1,766,502 2019-08-29 0

    JACOBS JOAN

    • 10% Owner
    1,766,502 2019-08-29 0

    COWEN INC.

    COWEN INVESTMENTS II LLC

    COWEN AND COMPANY, LLC

    COWEN HOLDINGS, INC.

    RCG LV PEARL LLC

    SOLOMON JEFFREY M

    • 10% Owner
    919,296 2019-03-26 0

    POLAR ASSET MANAGEMENT PARTNERS INC.

    • 10% Owner
    No longer subject to file 2019-03-21 0

    SHUKLA RAJIV CEO & CHAIRMAN

    CENTRIPETAL, LLC

    • Officer
    • Director
    • 10% Owner
    3,882,500 2017-06-23 0

    ROSLING ALAN

    • Director
    0 2017-06-19 0

    HANDA KEWAL

    • Director
    0 2017-06-19 0

    POLLAK CRAIG CFO AND SECRETARY

    • Officer
    0 2017-06-19 0

    ALEXANDER JOHN JOSEPH

    • Director
    0 2017-06-19 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments